Bio-Rad Laboratories | BIO - Capital Ordinário





Capital Ordinário Alterar Data
Abbott USD 1.74B 2.94M 2026-03
Agilent USD 281.97M 252K 2026-06
Becton, Dickinson and Co. USD 272.39M 98.21M 2026-09
Bio Techne USD 157.05M 959K 2026-09
Bio-Rad Laboratories USD 26.74M 91K 2026-06
Bruker USD 152.35M 130K 2026-06
Charles River Laboratories USD 47.88M 148K 2026-09
Danaher USD 703.4M 500K 2026-09
General Electric Aerospace USD 1.03B 4.21M 2026-09
Illumina USD 151.3M 607K 2026-06
IQVIA Holdings USD 164.8M 200K 2026-09
Laboratory Of America USD 81.2M 300K 2026-09
Merck USD 2.47B 1.05M 2026-06
Mettler Toledo International USD 20.21M 40.9K 2026-06
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Pacific Biosciences Of California USD 301.96M 103K 2025-12
Quest Diagnostics USD 110M 0 2026-09
Repligen USD 56.69M 266K 2026-09
Revvity USD 111.59M 43K 2026-09
Roche Holding CHF 796.77M 1.15M 2026-06
Siemens EUR 762.74M 0 2026-06
Standard Biotools USD 392.12M 1.98M 2026-06
Thermo Fisher Scientific USD 369.75M 1.88M 2026-09
Tosoh JPY 307.99M 103K 2026-09
Waters USD 98.19M 20K 2026-06